(Q43722386)

26 November 2017

title

Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells (English)

1 reference

26 November 2017

3

1 reference

26 November 2017

6

1 reference

26 November 2017

Kampa M

1

1 reference

26 November 2017

Hatzoglou A

series ordinal

2

1 reference

26 November 2017

Niniraki M

series ordinal

4

1 reference

26 November 2017

Kouroumalis E

series ordinal

5

1 reference

26 November 2017

publication date

1 September 2001

1 reference

Cell Death & Differentiation

26 November 2017

published in

1 reference

26 November 2017

volume

8

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

943-952

1 reference

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Early alterations of actin cytoskeleton in OK cells by opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Differential properties of mu and delta opiate binding sites studied with highly selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Mammalian nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Guanylate cyclase and the .NO/cGMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

The dual personality of NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

The multifaceted roles of nitric oxide in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Effects of nitric oxide-related agents on opioid regulation of rat testicular steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Effects of acute administration of L-arginine on morphine antinociception and morphine distribution in central and peripheral tissues of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Inhibitory pathways and the inhibition of luteinizing hormone-releasing hormone release by alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Role of endothelial nitric oxide synthase in hypoxia-induced pial artery dilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Evidence for the involvement of nitric oxide and nitric oxide synthase in the modulation of opioid-induced antinociception and the inhibitory effects of exposure to 60-Hz magnetic fields in the land snail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Co-localization of mu-opioid receptor-like immunoreactivity with substance P-LI, calcitonin gene-related peptide-LI and nitric oxide synthase-LI in vagal and glossopharyngeal afferent neurons of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Nociceptin inhibits tonic nitric oxide release in the mouse isolated proximal colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Structures of redox enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Opioids inhibit the induction of nitric oxide synthase in J774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Heroin modulates the expression of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Kinetic properties of nitric oxide synthase in cerebral cortex and cerebellum of morphine tolerant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Receptor-induced internalization of selective peptidic mu and delta opioid ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

beta-Endorphin: surface binding and internalization in thymoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Kappa opioid receptor endocytosis by dynorphin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

Catalysis by nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

The effect of N-nitro-L-arginine methyl ester on morphine-induced changes in the plasma corticosterone and testosterone levels in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Nitric oxide and opioid tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Met-enkephalin receptor-mediated increase of membrane fluidity modulates nitric oxide (NO) and cGMP production in rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Further evidence that nitric oxide modifies acute and chronic morphine actions in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Intravenous beta-endorphin administration fails to alter hypothalamic blood flow in rats expressing normal or reduced nitric oxide synthase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Augmenting effect of opioids on nitrite production by stimulated murine macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Chronic morphine exposure and the expression of heme oxygenase type 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Evidence for the role of nitric oxide in κ-opiate tolerance in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Quantitation of nitrate and nitrite in extracellular fluids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Phagocytosis is regulated by nitric oxide in murine microglia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400893

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4400893

1 reference

Dimensions Publication ID

26 November 2017

1043947468

0 references

1 reference